논문KCI 등재
Correspondence to editorial on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (11)
관련 논문AI추천
Reply to correspondence on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”Hyuk Soo Eun대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Circulating cell-free mitochondrial DNA for diagnosing hepatocellular carcinoma and assessing prognosis: Editorial on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”Hyuk Soo Eun대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”Hyo Jung Cho, Su Bin Lim대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Correspondence to editorial on “Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma”Kwang-Woong Lee, Young-Joon Kim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Aberrant fragmentomic features of circulating cellfree mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinomaFan Peng, Huanmin Jiao, Huanqin Zhang, Jinliang Xing, Kaixiang Zhou, Miao Dang, Shanshan Guo, Siyuan Wang, Weizheng Zhou, Wenjie Guo, Xu Guo, Yang Liu대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: A gateway to personalized medicine: Editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”Joseph C Ahn, Ju Dong Yang대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호
이 간행물의 다른 논문 (84건)
Epidemiology of metabolic dysfunction-associated steatotic liver diseaseLinda Henry, Markos Kalligeros, Zobair M. Younossipp. 32-50Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver diseaseJimmy Che-To Lai, Sherlot Juan Song, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Yichong Jiang, Yue Wangpp. 51-75Precision medicine and nucleotide-based therapeutics to treat steatotic liver diseaseAndrea Caddeo, Stefano Romeopp. 76-93Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver diseaseJasmohan S. Bajaj, Jeremy Burton, Antonio Gil-Gómez, Huma Saeed, Juan Pablo Arab, Luis Antonio Díaz, Manuel Romero-Gomez, Marco Arrese, Mohammad Qasim Khanpp. 94-111Alcohol-associated liver disease: Natural history, management and novel targeted therapiesHugo López-Pelayo, Edilmar Alvarado-Tapias, Ana Clemente-Sánchez, Ramón Bataller, Jordi Gratacós-Ginès, Elisa Posepp. 112-133